Home > Boards > US Listed > Computers - Hardware > Anixa Biosciences (ANIX)

ITUS buy 3.60

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 461
Posts 10,048
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/9/2021 4:16:07 PM
Anixa advancing COVID-19 antiviral candidates to preclinical stage Seeking Alpha - 4/5/2021 9:28:14 AM
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic PR Newswire (US) - 4/5/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2021 4:03:46 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 3/30/2021 5:48:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/26/2021 11:07:06 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/26/2021 9:42:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/24/2021 4:29:37 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/24/2021 4:15:58 PM
Anixa Biosciences plunges on upsizing stock offering to $22.5M Seeking Alpha - 3/23/2021 8:31:44 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 3/23/2021 6:08:18 AM
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million PR Newswire (US) - 3/22/2021 10:00:00 PM
Anixa Biosciences to raise $10M in bought deal offering Seeking Alpha - 3/22/2021 5:33:02 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 3/22/2021 5:25:46 PM
Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock PR Newswire (US) - 3/22/2021 5:18:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/22/2021 5:16:56 PM
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy PR Newswire (US) - 3/22/2021 8:30:00 AM
Anixa Bio shares surge 35% on European patent for ovarian cancer vaccine technology Seeking Alpha - 3/12/2021 8:43:29 AM
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology PR Newswire (US) - 3/12/2021 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 3/11/2021 4:32:03 PM
Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference PR Newswire (US) - 3/8/2021 8:30:00 AM
Anixa issued European patent for CAR-T cancer therapy Seeking Alpha - 3/4/2021 8:54:38 AM
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy PR Newswire (US) - 3/4/2021 8:30:00 AM
Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire (US) - 2/25/2021 8:30:00 AM
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates PR Newswire (US) - 2/16/2021 8:30:00 AM
stocktrademan   Wednesday, 02/14/18 05:32:28 PM
Re: stocktrademan post# 633
Post # of 697 
ITUS buy 3.60



















normal chart




log chart





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences